Avatar Medical and Barco Evolve Exam Room Imaging with the Launch of Eonis Vision

Avatar Medical and Barco Evolve Exam Room Imaging with the Launch of Eonis Vision

New 3D imaging solution brings Avatar Medical's 3D visualization software and Barco's glasses-free 3D display together, transforming the patient consultation into a shared, real-time experience.

Avatar Medical and Barco today announced Eonis Vision, marking a new evolution in how medical imaging is experienced during patient consultations. Avatar Medical, a pioneer in transforming medical imaging into shared understanding, and Barco, a global leader in visualization and collaboration technology, combine their hardware and software products into Eonis Vision, uniting advanced 3D imaging with a breakthrough display experience that brings anatomy to life, right in the exam room.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251120028901/en/

Photo Credit: Avatar Medical

Photo Credit: Avatar Medical

Immersive 3D for clinical environments

Using Barco's new glasses-free autostereoscopic display, Avatar Medical's software converts CT and MRI scans into spatially accurate, lifelike 3D anatomical avatars with no headset or specialized goggles required. This contributes to faster clarity in consultations, stronger trust between physician and patient, and clinical decisions made through shared understanding rather than 2D interpretation.

"Eonis Vision turns medical imaging into shared understanding and trust," said Elodie Litzler, PhD, co-founder and Chief Operations Officer at Avatar Medical. "When physicians and patients can see together, they decide together - because in medicine, seeing is healing."

Seamless workflow integration

Optimized for clinical use, Eonis Vision combines high-speed rendering with seamless workflow integration. Launched directly from a patient's medical record, it retrieves imaging studies instantly and transforms them into interactive 3D anatomy without altering existing clinical routines. This helps clinicians achieve faster, clearer communication and more confident decision-making in every consultation.

"I have used Avatar Medical Vision in my breast cancer practice, and patients have loved it. It has truly helped them better understand their diagnosis and feel more engaged in their care," said Dr. Myriam Delomenie, Oncologic Surgeon at the American Hospital of Paris. "I am eager to evaluate Eonis Vision, especially its ability to bring depth and clarity into the consultation room, which could help patients feel more supported and more confident as they move forward with treatment."

World's first glasses-free medical 3D display

"Barco has always believed that clarity drives confidence," said Dirk Feyants, Executive Vice President for Diagnostics, Barco. "By bringing Eonis Vision to life on our Eonis 3D display, we're creating shared visualization experiences that connect doctors and patients in more meaningful ways, right where care decisions are made. Built on Leia's Immersity platform, our Eonis 3D is the world's first glasses-free medical 3D display solution. It transforms complex anatomical data into intuitive, depth-rich experiences."

"Barco has long set the standard for innovation in medical visualization," said Fabio Esposito, Chief Executive Officer, Leia, Inc. "By integrating Leia's Immersity Platform, they're the first to bring true immersive experiences into clinical settings. This technology makes physicians and patients feel they are in touch with the scene - enhancing understanding, improving communication, and defining what's next in healthcare."

Boosting patient understanding

Early assessments in hospitals across the U.S. and Europe are already demonstrating that surgical consults are transforming from uncertainty to comprehension. Unlike traditional imaging platforms that require time-intensive segmentation and interpretation, Eonis Vision delivers real-time, collaborative visualization that deepens patient engagement and supports shared decision-making.

Key Features:

  • Instant 3D conversion – Converts CT and MRI scans into lifelike 3D avatars instantly, with no manual segmentation required.
  • True stereoscopic depth – Delivers autostereoscopic (glasses-free) 3D visualization that provides natural depth perception without special eyewear, enabling physicians and patients to view anatomy as it exists in real space.
  • Seamless workflow integration – Launches directly from the patient's medical record and connects to Picture Archiving Communication System (PACS) to enhance clinical efficiency.
  • Collaborative visualization – Enables physicians and patients to explore anatomy together, building understanding and trust.
  • High precision and performance – Delivers real-time rendering and accuracy designed for the speed and reliability of clinical environments.
  • Patient-centered clarity – Turns complex imaging into clear, intuitive visuals that foster comfort and confidence.

Partnership and Collaboration

The partnership between Avatar Medical and Barco combines two complementary areas of innovation and expertise: Avatar Medical's strength in clinical 3D imaging and workflow design, and Barco's leadership in medical visualization solutions. Together, the companies bridge the gap between medical imaging and medical understanding, enabling faster, clearer, and more human-centered communication in clinical care. This collaboration represents a step toward the Clinic of the Future, where technology enhances empathy and knowledge becomes comfort.

RSNA 2025

The companies will debut Eonis Vision at RSNA 2025, held November 30 - December 4, 2025, in Chicago, where clinicians and healthcare leaders can experience consult-driven imaging firsthand. Visit Avatar Medical at Booth #7701 and Barco at Booths #1916 and #1719.

Availability

Eonis Vision is a bundled solution that combines Avatar Medical Vision software with Barco's medical-grade Eonis 3D display. While Avatar Medical Vision is FDA-cleared (K222035), the new version, which enables compatibility with the Eonis 3D display, will be commercially available post-FDA clearance. Barco's Eonis 3D display is expected to be commercially available by the end of November 2025.

Sales and Partnership Inquiries:

Please contact Avatar Medical at sales@avatarmedical.ai .

About Barco

Barco, headquartered in Kortrijk (Belgium), is a global technology company leading in visualization, networking, and collaboration solutions. Its innovative technologies drive advancements in the healthcare, enterprise, and entertainment markets. At the heart of Barco's success are over 3,000 dedicated ‘visioneers', each passionately contributing to driving change through technology.

Listed on Euronext (BAR), Reuters (BARBt.BR), and Bloomberg (BAR BB), Barco realized sales of 947 million euros in 2024. For further insights, please visit www.barco.com or connect on LinkedIn , YouTube , Instagram , and Facebook .

About Avatar Medical

Founded in 2020, Avatar Medical is leading the evolution from medical imaging to medical understanding. By transforming CT and MRI scans into intuitive, lifelike 3D avatars, instantly and without segmentation. The company's flagship product, Avatar Medical Vision, empowers physicians to communicate more effectively, improve workflow efficiency, and build trust through shared understanding. Backed by research from Institut Curie and Institut Pasteur and strengthened by a strategic partnership with Barco, the company is advancing the Clinic of the Future across the U.S., Europe, and Asia. Seeing is Healing. Learn more at avatarmedical.ai .

MEDIA CONTACTS:

BARCO
Inge Govaerts, Corporate Communications Officer, +32 56 36 80 52, inge.govaerts@barco.com

AVATAR MEDICAL
David Templeton, ANW Networks, +1 203.530.0458, dtempleton@anwnetworks.com
Alicia V. Nieva-Woodgate, ANW Networks, +1 720.808.0086, alicia@anwnetworks.com

News Provided by Business Wire via QuoteMedia

BAR
The Conversation (0)
Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

Potentially Valuable Novel Compositions Being InvestigatedLexaria Also Receives Additional New Granted Patent KELOWNA, BC / ACCESS Newswire / June 23, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides the following... Keep Reading...
New Found Gold Provides Hammerdown Update

New Found Gold Provides Hammerdown Update

Delivery to the Mill nearing steady-state requirements, with gold reconciling from the block model to the MillFully staffed with 40 new jobs created to date and over 90% of new hires from the provinceProject remains on schedule for commercial production in H2/26New Found Gold Corp. (TSXV: NFG)... Keep Reading...
Corcel Drills 56.65 Meters of 1.07% Cu, 0.79 g/t Au and 7.1 g/t Ag in the First Drill Hole at the Yuma King Project, Arizona

Corcel Drills 56.65 Meters of 1.07% Cu, 0.79 g/t Au and 7.1 g/t Ag in the First Drill Hole at the Yuma King Project, Arizona

Corcel Exploration Inc. (CSE: CRCL,OTC:CRLEF) (OTCQB: CRLEF) (the "Company" or "Corcel") is pleased to announce assay results from the first drill hole of the recently completed, Phase 1 drill program at the Yuma King Project (the "Project") located in west-central Arizona. Drill hole YK26-001... Keep Reading...
Exploration Expands the High-Grade Silver-Lead Cate-8 Vein Discovered in the Upper Area of the Mine

Exploration Expands the High-Grade Silver-Lead Cate-8 Vein Discovered in the Upper Area of the Mine

Bunker Hill Mining Corp. ("Bunker Hill" or the "Company") (TSX: BNKR | OTCQB: BHLL) reports further successful results from the ongoing exploration drill program testing the high-grade silver-lead Cate-8 Vein discovery adjacent to current development in the upper area of the Bunker Hill mine... Keep Reading...
A Fully Funded Junior in the Middle of a Q2 Catalyst Window: NevGold Heads Into Maiden Antimony-Gold MRE With C$42.2M in the Treasury

A Fully Funded Junior in the Middle of a Q2 Catalyst Window: NevGold Heads Into Maiden Antimony-Gold MRE With C$42.2M in the Treasury

Baystreet.ca News Commentary Issued on behalf of Nevgold Corp.Nevgold Corp. (TSX-V: NAU | OTCQX: NAUFF | FRA: 5E50) closes one of the most catalyst-dense six-week stretches in its corporate history — upsized brokered financing, 1.11% antimony drill hits, up to 99% gold recovery metallurgy, and a... Keep Reading...
Gold bars on US money.

WGC: Gold to Hold Near US$4,100 in Second Half of 2026

The global gold price will remain rangebound around US$4,100 per ounce in the second half of 2026 under current conditions, according to the World Gold Council’s (WGC) mid-year outlook report.The projection follows a period of high price volatility for the yellow metal. Spot gold reached an... Keep Reading...
Will Rhind, gold bars.

Will Rhind: Gold Price Takes a Hit, This Catalyst to Drive Next Leg

Will Rhind, CEO of GraniteShares, weighs in on gold's pullback below US$4,000 per ounce, identifying what needs to happen for the price to rise. "The trend I think in terms of the dollar cycle has to reverse," he explained. "In other words, the dollar has to start getting weaker on a more... Keep Reading...
Gold bars in stacks with words "5 Top Canadian Mining Stocks This Week" on top.

Top 5 Canadian Mining Stocks This Week: Grande Portage Resources Gains 32 Percent

Welcome to the Investing News Network's weekly look at the best-performing Canadian mining stocks on the TSX, TSXV and CSE, starting with a round-up of Canadian news impacting the resource sector.Statistics Canada released May’s consumer price index data on Monday (June 22). The data shows that... Keep Reading...
Rhona O'Connell.

Rhona O'Connell: Gold Price Drop — Why it Happened, What's Next

Rhona O'Connell, StoneX's head of market analysis, EMEA and Asia, breaks down gold's price activity over the last six months, including its correction at the beginning of the year and this week's fall below the much-watched US$4,000 per ounce level. Although the metal is now back above US$4,000,... Keep Reading...
Wooden blocks with arrows and "GOLD PRICE" text sit on piles of gold coins against a black background.

Gold Price Falls Below US$4,000, How Low Can it Go?

Gold is feeling the summer heat with a drop below US$4,000 per ounce on Wednesday (June 24). The yellow metal hasn't been below that key psychological level since November 2025, but a stronger US dollar, expectations of higher interest rates and cooling tensions in the Middle East are combining... Keep Reading...
Guinea flag.

Guinea Bans Raw Gold Exports to Force Domestic Refining

Guinea has banned the export of raw gold effective immediately, requiring all industrial and artisanal miners to process the precious metal domestically before shipping.According to a Bloomberg report, Guinean President Mamadi Doumbouya announced the policy during a meeting with mining... Keep Reading...

Interactive Chart

Latest Press Releases

Related News